Business Wire

Arcserve Acquires Zetta, Enterprise-Cloud Disaster Recovery Provider

Del

Arcserve, LLC, whose breakthrough data protection and availability solutions deliver enterprise power with small team simplicity, today announced the acquisition of Zetta, a leader in cloud-first disaster recovery (DR) solutions and data centre IP. Zetta’s offerings provide organisations with direct-to-cloud disaster recovery as a service (DRaaS) and backup as a service (BaaS) to quickly and reliably protect, access and recover virtual and physical data without the need for extra hardware. The terms of the transaction were not disclosed. This transaction further increases Arcserve’s market share on the heels of the company’s recent email archiving technology acquisition.

“The acquisition of Zetta advances our cloud solution with technology, data centres and expertise that places Arcserve at the forefront of the backup and recovery industry,” said Mike Crest, CEO of Arcserve. Jeff Whitehead, CTO of Arcserve and former CTO of Zetta, added, “Arcserve and Zetta share the same passionate focus on customer success and delivering the world’s foremost data protection innovation. Becoming a part of Arcserve presents us with an amazing opportunity to invest further in our technology and gives our customers access to a broader portfolio of data protection solutions with continued global support.”

“Organisations of all sizes are looking to cloud technologies as part of their IT acceleration strategies; especially with regard to backup and BC/DR. Arcserve is making the right strategic move at a critical juncture in this market,” said Jason Buffington, principal analyst at ESG. “The addition of Zetta is clearly a good fit for mid-market customer needs today. Zetta’s leading cloud technologies, combined with Arcserve’s rich data protection solutions, provide a compelling breadth of capabilities that demonstrates Arcserve’s continued evolution and reinvention in this market.”

Complete and Seamless Cloud Backup and Disaster Recovery

With the purchase of Zetta, Arcserve’s flagship Unified Data Protection (UDP) solution suite will now include Arcserve UDP Cloud Direct, its new direct-to-cloud DRaaS and BaaS offerings, ideal for:

  • Businesses who need a quick and simple cloud on-ramp without on-premise hardware requirements, such as in branch or small offices where on-premise may not be desired or practical
  • Users who want a seamless cloud networking, automation and management platform, and who wish to automatically and securely move large volumes of data over networks to data centres worldwide
  • Organisations with systems that cannot tolerate downtime and want to benefit from rapid push-button failover of an entire IT environment in minutes, industry-leading cloud backup speeds and 100 percent recoverability with validated data integrity
  • Channel partners looking to efficiently and profitably adopt and manage cloud offerings, with features such as multitenancy, multi-customer administration, tracking, and invoicing

Arcserve currently offers its cloud service through Arcserve UDP in a hybrid backup model, whereby users automatically replicate backup images from an on-premise recovery point server (RPS) to a corresponding RPS in the cloud (disk-to-disk-to-cloud). By converging direct-to-cloud and hybrid cloud technologies into one solution, IT teams can now implement on premises, hybrid cloud and direct to cloud from a single pane of glass.

Arcserve Shatters Notion of Recovery with the First Platform-Comprehensive Near-Zero Data Loss Solution

Recognising that a growing number of organisations are deploying systems with zero tolerance for more than a few seconds of data loss, Arcserve today announced a disaster avoidance platform that will enable its customers to move beyond recovering data in the event of a disaster to avoiding the disaster altogether.

“Midsize and decentralised organisations are being overwhelmed by enterprise expectations, whereby they’re expected to adhere to stricter service level availability agreements without enterprise budgets,” said Crest. “This is where the challenge lies: these organisations cannot afford the complex and expensive solutions offered by some vendors, nor can they justify DRaaS solutions that may recover systems quickly but are recovering hours-old data. That’s a huge market gap we will fill.”

The company will soon deliver a comprehensive and affordable near-zero data loss recovery point objective (RPO) solution with near-instant recovery time objective (RTO) priced affordably for midsize and decentralised enterprise organisations. Arcserve is already building out this solution by combining its replication and high availability engine with its new cloud-first DRaaS offerings and data centre IP. Continued Crest, “Over the coming months, we’ll change the game with an affordable, completely seamless solution that will limit customers’ data loss to nearly zero and will support all midmarket platforms, hypervisors, cloud and on-premises, ultimately making DRaaS solutions that lose hours of data a relic of the past.”

Availability

Arcserve’s new direct-to-cloud solution, Arcserve UDP Cloud Direct, will be available through its North American partner network this summer, with broader availability and local data centres in EMEA this autumn, and Japan within the year. The availability of the current Arcserve UDP hybrid cloud service is unaffected. Current Zetta customers will continue to be fully supported.

Follow Arcserve

About Arcserve

Arcserve develops breakthrough data protection and availability solutions that deliver enterprise power with small team simplicity. Launched in 1990 as a product under Cheyenne Software, Arcserve became an independent organisation in 2014 and released the first solution, Arcserve Unified Data Protection (UDP), to deliver comprehensive backup and recovery across cloud, virtual and physical environments under one pane of glass. Since then, Arcserve has continuously redefined data protection, with a full range of highly efficient and integrated capabilities, deployable on-premise or in the cloud, with high availability, disaster recovery, backup and recovery, and data archiving. Arcserve has a customer base of 45,000 end users in more than 150 countries and partners with over 7,500 distributors, resellers and service providers around the world. It is headquartered in Minneapolis, Minnesota. Visit www.arcserve.com.

###

Contact information

A3 Communications - the PR specialists for storage and virtualization companies
Fiona Hatton
+44 (0) 1252 875 203
arcserve@a3communications.co.uk

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20Pressemelding

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31Pressemelding

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

Double Win for Vocalink at the 2017 Payments Awards17.11.2017 09:35Pressemelding

Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom